SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000819050-22-000039
Filing Date
2022-05-09
Accepted
2022-05-09 16:07:38
Documents
1
Period of Report
2022-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165212683403310.html 4  
1 FORM 4 wf-form4_165212683403310.xml 4 4034
  Complete submission text file 0000819050-22-000039.txt   5504
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5777 CENTRAL AVENUE, SUITE 102 BOULDER CO 80301
Business Address
Sklawer Andrew D (Reporting) CIK: 0001782334 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21088 | Film No.: 22904932